NO962536D0 - 6-(2-imidazolinylamino)kinolin-forbindelser anvendbare som -2-adrenoceptor-agonister - Google Patents

6-(2-imidazolinylamino)kinolin-forbindelser anvendbare som -2-adrenoceptor-agonister

Info

Publication number
NO962536D0
NO962536D0 NO962536A NO962536A NO962536D0 NO 962536 D0 NO962536 D0 NO 962536D0 NO 962536 A NO962536 A NO 962536A NO 962536 A NO962536 A NO 962536A NO 962536 D0 NO962536 D0 NO 962536D0
Authority
NO
Norway
Prior art keywords
unsubstituted
imidazolinylamino
alkanyl
alkenyl
compounds
Prior art date
Application number
NO962536A
Other languages
English (en)
Other versions
NO308662B1 (no
NO962536L (no
Inventor
Thomas Lee Cupps
Peter Julian Maurer
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/326,564 external-priority patent/US5578607A/en
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO962536D0 publication Critical patent/NO962536D0/no
Publication of NO962536L publication Critical patent/NO962536L/no
Publication of NO308662B1 publication Critical patent/NO308662B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO962536A 1993-12-17 1996-06-14 6-(2-imidazolinylamino)kinolinforbindelser, anvendelser derav, og farmasøytiske preparater omfattende slike forbindelser NO308662B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16934393A 1993-12-17 1993-12-17
US08/326,564 US5578607A (en) 1993-12-17 1994-10-20 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
PCT/US1994/014293 WO1995016683A1 (en) 1993-12-17 1994-12-15 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists

Publications (3)

Publication Number Publication Date
NO962536D0 true NO962536D0 (no) 1996-06-14
NO962536L NO962536L (no) 1996-08-02
NO308662B1 NO308662B1 (no) 2000-10-09

Family

ID=26864975

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962536A NO308662B1 (no) 1993-12-17 1996-06-14 6-(2-imidazolinylamino)kinolinforbindelser, anvendelser derav, og farmasøytiske preparater omfattende slike forbindelser

Country Status (23)

Country Link
US (1) US5739148A (no)
EP (1) EP0736020B1 (no)
JP (1) JPH09511483A (no)
CN (1) CN1046718C (no)
AT (1) ATE192150T1 (no)
AU (1) AU699041B2 (no)
BR (1) BR9408335A (no)
CA (1) CA2179264C (no)
CZ (1) CZ285481B6 (no)
DE (1) DE69424183T2 (no)
DK (1) DK0736020T3 (no)
ES (1) ES2146307T3 (no)
FI (1) FI962491A (no)
GR (1) GR3033515T3 (no)
HK (1) HK1013072A1 (no)
HU (1) HU217841B (no)
NO (1) NO308662B1 (no)
NZ (1) NZ333370A (no)
PL (1) PL180392B1 (no)
PT (1) PT736020E (no)
SG (1) SG55141A1 (no)
SK (1) SK77096A3 (no)
WO (1) WO1995016683A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW527355B (en) * 1997-07-02 2003-04-11 Bristol Myers Squibb Co Inhibitors of farnesyl protein transferase
WO2005089504A2 (en) * 2004-03-18 2005-09-29 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
US20070293539A1 (en) * 2004-03-18 2007-12-20 Lansbury Peter T Methods for the treatment of synucleinopathies
WO2005089496A2 (en) * 2004-03-18 2005-09-29 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
WO2005089502A2 (en) * 2004-03-18 2005-09-29 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
WO2005089515A2 (en) * 2004-03-18 2005-09-29 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
US20080076738A1 (en) * 2004-04-14 2008-03-27 Cai Zhenhong R Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds
CN101355876B (zh) 2005-11-09 2012-09-05 康宾纳特克斯公司 一种适用于眼部给药的组合物
US8232402B2 (en) * 2008-03-12 2012-07-31 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
EP2370436A1 (en) * 2008-11-13 2011-10-05 Link Medicine Corporation Azaquinolinone derivatives and uses thereof
US20100331363A1 (en) * 2008-11-13 2010-12-30 Link Medicine Corporation Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
US20110060005A1 (en) * 2008-11-13 2011-03-10 Link Medicine Corporation Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
US8815861B2 (en) * 2011-07-25 2014-08-26 Allergan, Inc. N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029792A (en) * 1972-02-29 1977-06-14 Pfizer Inc. (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents
BE795970A (fr) * 1972-02-29 1973-08-27 Pfizer Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant
US4036976A (en) * 1973-04-05 1977-07-19 Sandoz, Inc. Substituted imidazolinylamino-indazoles
US4217356A (en) * 1975-08-22 1980-08-12 Sandoz Ltd. 2-Imidazolinylamino-2,1,3-benzothiadiazoles
US4398028A (en) * 1977-01-14 1983-08-09 Sandoz Ltd. Bicyclic heterocyclic amino derivatives
EP0025269B1 (en) * 1979-08-23 1985-11-13 Beecham Group Plc Anti-diarrhoea veterinary composition
WO1982000824A1 (en) * 1980-09-05 1982-03-18 Geissmann F 1h and 2h indazol derivatives and medicaments containing them
FR2638356A1 (fr) * 1988-10-28 1990-05-04 Anben Nouveaux derives de la 2-arylimino-imidazolidine pour diminuer la pression intra-oculaire et traiter le glaucome
US5281591A (en) * 1989-05-22 1994-01-25 Allergan, Inc. Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5021410A (en) * 1989-05-22 1991-06-04 Allergan, Inc. Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5180721A (en) * 1989-05-22 1993-01-19 Allergan, Inc. Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5231096A (en) * 1989-10-12 1993-07-27 Allergan, Inc. Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
US5021416A (en) * 1989-10-31 1991-06-04 Allergan, Inc. Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure
US5091528A (en) * 1990-09-12 1992-02-25 Allergan, Inc. 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents

Also Published As

Publication number Publication date
HU9601659D0 (en) 1996-08-28
DK0736020T3 (da) 2000-08-07
CZ285481B6 (cs) 1999-08-11
FI962491A (fi) 1996-07-26
WO1995016683A1 (en) 1995-06-22
AU1306395A (en) 1995-07-03
CN1046718C (zh) 1999-11-24
PL315060A1 (en) 1996-09-30
GR3033515T3 (en) 2000-09-29
NZ333370A (en) 2001-03-30
NO308662B1 (no) 2000-10-09
DE69424183T2 (de) 2001-02-15
HU217841B (hu) 2000-04-28
EP0736020A1 (en) 1996-10-09
ATE192150T1 (de) 2000-05-15
CN1137793A (zh) 1996-12-11
NO962536L (no) 1996-08-02
ES2146307T3 (es) 2000-08-01
CA2179264A1 (en) 1995-06-22
BR9408335A (pt) 1997-08-19
SG55141A1 (en) 1998-12-21
HUT76277A (en) 1997-07-28
SK77096A3 (en) 1997-02-05
CZ175396A3 (en) 1996-11-13
PT736020E (pt) 2000-10-31
HK1013072A1 (en) 1999-08-13
DE69424183D1 (de) 2000-05-31
JPH09511483A (ja) 1997-11-18
EP0736020B1 (en) 2000-04-26
CA2179264C (en) 1999-05-18
PL180392B1 (pl) 2001-01-31
FI962491A0 (fi) 1996-06-14
US5739148A (en) 1998-04-14
AU699041B2 (en) 1998-11-19

Similar Documents

Publication Publication Date Title
NO962539D0 (no) 5-(2-imidazolinylamino)benzimidazol-derivater, deres fremstilling og deres anvendelse som -2-adreniceptor-agonister
NO962536L (no) 6-(2-imidazolinylamino)kinolin-forbindelser anvendbare som -2-adrenoceptor-agonister
FI962493A0 (fi) Alfa-2-adrenoseptoriagonisteina käyttökelpoisia 6-(2-imidatsolinyyliamino)kinoksaliiniyhdisteitä
FI962492A0 (fi) Alpha-2-adrenoseptoriagonisteina käyttökelpoisia 7-(2-imidatsolinyyliamino)kinoliiniyhdisteitä
FI920435A (fi) N-(aryloxyalkyl) heteroaryl-8 -azabicyclo/3.2.1./oktaner, mellanprodukter och deras framstaellnings -foerfarande och deras anvaendning som laekemedel.
KR950002761A (ko) 강박 반응 장애 치료제 제조용으로서의 n-(피리디닐)-1h-인돌-1-아민의 용도
DE69827614D1 (de) Chinoxalindionen
KR910000150A (ko) 대사성 골 질환 치료제
BR0209065A (pt) Sulfato de composto de cefemo

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees